PolypathologyGERONTACCESSNCT04008472
Telemedicine - Evaluation of the Impact of a Telemedicine Device (DTM) on the Prevention of Emergency Department Visits and Hospitalizations of Nursing Home Residents Aged Polypathological
A study testing Telemedecine in people with Polypathology, run by University Hospital, Limoges at 1 site in France.
Trial summary
For several decades, there is an aging population, particularly in industrialized countries. This lengthening of the duration of life is accompanied by an increase in the number of chronically ill patients. Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Polypathology
- What is being tested?
- Telemedecine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 428 participants
- Where
- 1 siteFrance
- Study dates
- Nov 2015to May 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Resident in one of 9 nursing homes participating in the project
- Resident polypathologique has at least two comorbidities
- Having made no request to change place of residence at the time of the inclusion visit
- Having given free consent, informed writing and signed by himself and / or his legal representative
Who cannot join
- Unaffiliated resident or non-receiving of social security
- severe pathology (ies) involving life-threatening in the short term
- Resident whose return home, transfer to another nursing home or to a long term care unit is programmed
Trial locations and contacts
1 site in 1 country.
About this study
For several decades, there is an aging population, particularly in industrialized countries. This lengthening of the duration of life is accompanied by an increase in the number of chronically ill patients. On an estimate of 15 million patients in France today, the figure reported for 2020 would be 20 million patients. Chronic diseases are responsible for functional decompensation and admission responsible autonomy breaks in nursing homes (Accommodation Establishment of People Dependent Elderly).
An estimated 700,000 the number of people currently living in retirement homes in France. These residents are mostly dependent and multiple pathologies requiring regular general and specialist medical monitoring . Medical concern demographic outlook and the need for access to quality care across the country leads to the development of telemedicine.
Read more
The need for telemedicine is not the same throughout the territory. It is less, or different, in highly urbanized areas where the density of health professionals is high, then it can be a new response to the needs of rural, isolated or landlocked. Telemedicine promotes the development of the concept of graduated care sector, especially in the management of patients with chronic diseases.
Telemedicine in rural nursing homes and can be a tool for assessing, monitoring and coordination to avoid decompensation of chronic conditions and rehospitalization.
This organization can afford to break the isolation of general practitioners and EHPAD coordinators physicians in rural areas and provide access to several specialties.
- Conditions
- Polypathology
- Being tested
- Telemedecine
- Keywords
- Telemedecine
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TelemedecineOther
Initiation of tele-medical consultation with the resident, a caregiver for the nursing home, the referring physician and geriatrician téléexpert. After a overall geriatric assessment in nursing homes by UPSAV the first teleconsultation is organized within 10 days. Subsequent visits are scheduled every 3 months for 12 months. Spontaneous visits can be requested at the initiative of the referring physician.
| Study group | Role | What they receive |
|---|---|---|
| Telemedecine | Experimental | Patients benefiting from telemedicine Receives: Other: Telemedecine |
| Control | No intervention | routine care without telemedecine |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation of telemedicine on prevention in old and polypathological patients
Proportion of patients with emergency admission or unscheduled hospitalization in medical or surgical service over 12 months.
Measured: After 12 months
Secondary outcomes (5)
Medico-economic impact
cost effectiveness of the telemedicine device
Measured: After 12 months
Impact on recurring hospitalizations
Number of readmissions
Measured: After 12 months
Impact on overall health
Number of emergency admissions Number of readmissions Number of days of hospitalization Number of medical consultations o
Measured: After 12 months
Impact on the quality of life ( EQ5D questionnary)
The EQ-5D (Europen Qyuality of llive) five dimension scale) questionnaire has two components: health state description and evaluation.
In the description part, health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Mobility dimension asks about the person's walking ability. Self-care dimension asks about the ability to wash or dress by oneself, and usual activities dimension measures performance in "work, study, housework, family or leisure activities". In pain/discomfort dimension, it asks how much pain or discomfort they have, and in anxiety/depression dimension, it asks how anxious or depressed they are.
Higher values represent a worse outcome.
The scale ranges from 5 to 15.
Measured: After 12 months
Impact on mortality
Proportion of patients who died at 12 months
Measured: After 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jul 2019
- Study startNov 2015
- Primary completionJan 2018
- Study completionMay 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PolypathologyStudies of the same condition, open and under way.
- More trials run by University Hospital, LimogesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 428 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Limoges
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Achille TCHALLA, Professor, Principal investigator, University Hospital, Limoges
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04008472
- Sponsor's protocol ID
- I14036 - GERONTACCESS
- Acronym
- GERONTACCESS
- Status last verified
- Jul 2019
- First submitted
- 2 Jul 2019
- Last updated
- 9 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Telemedicine - Evaluation of the Impact of a Telemedicine Device (DTM) on the Prevention of Emergency Department Visits and Hospitalizations of Nursing Home Residents Aged Polypathological
- ClinicalTrials.gov ID
- NCT04008472
- Acronym / sponsor ID
- GERONTACCESS / I14036 - GERONTACCESS
- Conditions
- Polypathology
- Keywords
- Telemedecine
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 428 participants (actual)
- Lead sponsor
- University Hospital, LimogesUniversity, hospital or other
- Study start
- Nov 2015 (actual)
- Primary completion
- Jan 2018 (actual)
- Study completion
- May 2019 (actual)
- First posted
- 5 Jul 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
For several decades, there is an aging population, particularly in industrialized countries. This lengthening of the duration of life is accompanied by an increase in the number of chronically ill patients. On an estimate of 15 million patients in France today, the figure reported for 2020 would be 20 million patients. Chronic diseases are responsible for functional decompensation and admission responsible autonomy breaks in nursing homes (Accommodation Establishment of People Dependent Elderly).
An estimated 700,000 the number of people currently living in retirement homes in France. These residents are mostly dependent and multiple pathologies requiring regular general and specialist medical monitoring . Medical concern demographic outlook and the need for access to quality care across the country leads to the development of telemedicine.
The need for telemedicine is not the same throughout the territory. It is less, or different, in highly urbanized areas where the density of health professionals is high, then it can be a new response to the needs of rural, isolated or landlocked. Telemedicine promotes the development of the concept of graduated care sector, especially in the management of patients with chronic diseases.
Telemedicine in rural nursing homes and can be a tool for assessing, monitoring and coordination to avoid decompensation of chronic conditions and rehospitalization.
This organization can afford to break the isolation of general practitioners and EHPAD coordinators physicians in rural areas and provide access to several specialties.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Telemedecine | Experimental | Other: TelemedecinePatients benefiting from telemedicine |
| Control | No intervention | –routine care without telemedecine |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Resident in one of 9 nursing homes participating in the project
- Resident polypathologique has at least two comorbidities
- Having made no request to change place of residence at the time of the inclusion visit
- Having given free consent, informed writing and signed by himself and / or his legal representative
Key exclusion criteria (3 listed)
- Unaffiliated resident or non-receiving of social security
- severe pathology (ies) involving life-threatening in the short term
- Resident whose return home, transfer to another nursing home or to a long term care unit is programmed
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TelemedecineInitiation of tele-medical consultation with the resident, a caregiver for the nursing home, the referring physician and geriatrician téléexpert. After a overall geriatric assessment in nursing homes by UPSAV the first teleconsultation is organized within 10 days. Subsequent visits are scheduled every 3 months for 12 months. Spontaneous visits can be requested at the initiative of the referring physician. | Other | Telemedecine |
Primary outcome
Evaluation of telemedicine on prevention in old and polypathological patients
Time frame: After 12 months
Proportion of patients with emergency admission or unscheduled hospitalization in medical or surgical service over 12 months.
5 secondary outcomes
Medico-economic impact
Time frame: After 12 months
Impact on recurring hospitalizations
Time frame: After 12 months
Impact on overall health
Time frame: After 12 months
Impact on the quality of life ( EQ5D questionnary)
Time frame: After 12 months
Impact on mortality
Time frame: After 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jun 2026.
Related trials for Polypathology
Not yet recruiting
Personalized Digital Remote Monitoring for Elderly Patients
Elderly Patients, Polypathology
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Achille TCHALLA, Professor principal investigator
University Hospital, Limoges
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Telemedecine in people with Polypathology, run by University Hospital, Limoges at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation of telemedicine on prevention in old and polypathological patients (time frame: After 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026.